Detalhe da pesquisa
1.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood
; 143(16): 1616-1627, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215395
2.
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.
Blood
; 137(25): 3473-3483, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33754642
3.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
N Engl J Med
; 379(26): 2517-2528, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501481
4.
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Blood
; 133(26): 2765-2775, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862645
5.
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440).
Haematologica
; 106(11): 2834-2844, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121235
6.
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
N Engl J Med
; 387(14): 1329-1331, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069925
7.
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
N Engl J Med
; 386(26): 2526-2528, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704428
8.
Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.
N Engl J Med
; 386(24): 2340-2342, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584183
9.
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia.
Blood
; 132(15): 1568-1572, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30111609
10.
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Blood
; 129(5): 553-560, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903528
11.
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts.
Blood
; 127(23): 2879-89, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013443
12.
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.
Blood
; 128(8): 1050-8, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27297790
13.
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors.
Haematologica
; 103(8): 1288-1297, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773600
14.
A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485.
Haematologica
; 103(6): 982-987, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567781
15.
Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis.
Am J Hematol
; 98(5): E116-E118, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808760
16.
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
Proc Natl Acad Sci U S A
; 112(7): 2169-74, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646413
17.
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
N Engl J Med
; 370(24): 2286-94, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24869598
18.
MuCor: mutation aggregation and correlation.
Bioinformatics
; 32(10): 1557-8, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26803155
19.
Computer-assisted quantification of CD3+ T cells in follicular lymphoma.
Cytometry A
; 91(6): 609-621, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28110507
20.
A phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphoma.
Blood
; 125(2): 242-8, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25355819